Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2004) | Total Docs. (3years) | Total Refs. (2004) |  Total Cites (3years) |
Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2004) | %Female (2004) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 141 | American Journal of Drug Delivery | journal | 23 | 20 | 0 | 1951 | 0 | 0 | 0.00 | 97.55 | 33.96 |  | |
| 140 | American Journal of PharmacoGenomics | journal | 1.175 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 139 | Chemical Speciation and Bioavailability | journal | 0.395 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 138 | Clinical Trials | journal | 74 | 60 | 0 | 1424 | 0 | 0 | 0.00 | 23.73 | 35.47 | | |
| 137 | Drug Discovery Today: Disease Mechanisms | journal | 28 | 65 | 0 | 2319 | 0 | 0 | 0.00 | 35.68 | 29.49 | | |
| 136 | Drug Discovery Today: Disease Models | journal | 33 | 64 | 0 | 2365 | 0 | 0 | 0.00 | 36.95 | 33.33 | | |
| 135 | Drug Discovery Today: Technologies | journal | 62 | 62 | 0 | 1799 | 0 | 0 | 0.00 | 29.02 | 21.31 | | |
| 134 | Drug Discovery Today: Therapeutic Strategies | journal | 31 | 74 | 0 | 2743 | 0 | 0 | 0.00 | 37.07 | 16.98 | | |
| 133 | Drug Discovery World | journal | 14 | 10 | 0 | 146 | 0 | 0 | 0.00 | 14.60 | 0.00 | | |
| 132 | EBR - European Biopharmaceutical Review | journal | 6 | 105 | 0 | 454 | 0 | 0 | 0.00 | 4.32 | 29.82 | | |
| 131 | Expert Opinion on Drug Delivery | journal | 133 | 16 | 0 | 1304 | 0 | 0 | 0.00 | 81.50 | 12.50 | | |
| 130 | International Antiviral News | journal | 0.101 Q4 | 8 | 0 | 25 | 0 | 0 | 23 | 0.00 | 0.00 | 0.00 | |
| 129 | Manufacturing Chemist | trade journal | 0.101 Q4 | 6 | 0 | 906 | 0 | 0 | 18 | 0.00 | 0.00 | 0.00 | |
| 128 | Particle and Fibre Toxicology | journal | 119 | 3 | 0 | 78 | 0 | 0 | 0.00 | 26.00 | 16.67 | | |
| 127 | Pharmaceutical Statistics | journal | 46 | 32 | 0 | 508 | 0 | 0 | 0.00 | 15.88 | 32.61 | | |
| 126 | Progress in Pharmaceutical and Biomedical Analysis | book series | 0.101 Q4 | 8 | 0 | 17 | 0 | 0 | 16 | 0.00 | 0.00 | 0.00 | |
| 125 | Toxicology Methods | journal | 0.234 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
| 124 | Advances in Antiviral Drug Design | book series | 0.106 Q4 | 12 | 0 | 7 | 0 | 1 | 7 | 0.14 | 0.00 | 0.00 | |
| 123 | European Journal of Herbal Medicine | journal | 0.102 Q4 | 3 | 5 | 23 | 46 | 1 | 14 | 0.00 | 9.20 | 50.00 | |
| 122 | Journal of Drug Evaluation | journal | 0.116 Q4 | 5 | 24 | 21 | 1440 | 1 | 9 | 0.05 | 60.00 | 21.43 | |
| 121 | BMC Chemical Biology | journal | 0.197 Q4 | 21 | 2 | 6 | 77 | 2 | 6 | 0.00 | 38.50 | 20.00 | |
| 120 | Pharmaceutical Visions | journal | 0.101 Q4 | 2 | 0 | 28 | 0 | 2 | 27 | 0.00 | 0.00 | 0.00 | |
| 119 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 102 | 199 | 226 | 4 | 143 | 0.02 | 2.22 | 25.44 | |
| 118 | Journal of Applied Therapeutic Research | journal | 0.129 Q4 | 8 | 19 | 18 | 388 | 4 | 18 | 0.22 | 20.42 | 37.29 | |
| 117 | Journal of Negative Results in BioMedicine | journal | 0.126 Q3 | 25 | 7 | 7 | 195 | 4 | 5 | 0.57 | 27.86 | 21.43 | |
| 116 | Pharmacy in Practice | journal | 0.112 Q4 | 6 | 62 | 97 | 352 | 4 | 79 | 0.06 | 5.68 | 56.90 | |
| 115 | Journal of Generic Medicines (discontinued) | journal | 0.224 Q2 | 16 | 43 | 11 | 543 | 5 | 10 | 0.45 | 12.63 | 34.21 | |
| 114 | Journal of Immune Based Therapies and Vaccines | journal | 0.264 Q3 | 21 | 9 | 5 | 367 | 6 | 4 | 1.20 | 40.78 | 46.81 | |
| 113 | Journal of Clinical Research | journal | 0.122 Q4 | 12 | 1 | 14 | 23 | 8 | 14 | 0.50 | 23.00 | 16.67 | |
| 112 | Cutaneous and Ocular Toxicology | journal | 0.127 Q4 | 37 | 27 | 71 | 740 | 9 | 68 | 0.18 | 27.41 | 39.56 | |
| 111 | Quality Assurance Journal | journal | 0.124 Q4 | 11 | 35 | 82 | 165 | 9 | 69 | 0.11 | 4.71 | 31.67 | |
| 110 | DARU, Journal of Pharmaceutical Sciences | journal | 0.115 Q4 | 58 | 32 | 84 | 693 | 11 | 83 | 0.11 | 21.66 | 22.64 | |
| 109 | Human Genomics | journal | 2.980 Q1 | 68 | 36 | 7 | 587 | 11 | 7 | 1.57 | 16.31 | 33.33 | |
| 108 | Drug Design and Discovery | journal | 0.296 Q3 | 20 | 0 | 17 | 0 | 12 | 16 | 0.75 | 0.00 | 0.00 | |
| 107 | Journal of Nanobiotechnology | journal | 0.449 Q2 | 109 | 12 | 6 | 343 | 12 | 6 | 2.00 | 28.58 | 7.14 | |
| 106 | Paediatric and Perinatal Drug Therapy | journal | 0.139 Q4 | 20 | 13 | 47 | 354 | 16 | 40 | 0.41 | 27.23 | 47.50 | |
| 105 | Reviews in Contemporary Pharmacotherapy | journal | 0.557 Q2 | 18 | 1 | 11 | 854 | 16 | 11 | 1.40 | 854.00 | 0.00 | |
| 104 | Pharmaceutical Medicine | journal | 0.148 Q4 | 25 | 27 | 114 | 574 | 17 | 79 | 0.13 | 21.26 | 27.08 | |
| 103 | Pharmacology Reviews and Communications | journal | 0.168 Q3 | 9 | 0 | 49 | 0 | 17 | 49 | 0.52 | 0.00 | 0.00 | |
| 102 | Comments on Toxicology | journal | 0.214 Q4 | 13 | 0 | 59 | 0 | 20 | 51 | 0.23 | 0.00 | 0.00 | |
| 101 | Toxicological Reviews | journal | 0.283 Q3 | 49 | 23 | 23 | 1767 | 22 | 22 | 0.96 | 76.83 | 20.00 | |
| 100 | Cytokines, Cellular and Molecular Therapy | journal | 0.283 Q3 | 28 | 0 | 21 | 0 | 24 | 21 | 1.14 | 0.00 | 0.00 | |
| 99 | Environmental Pollutants and Bioavailability | journal | 39 | 18 | 36 | 454 | 30 | 35 | 0.30 | 25.22 | 38.98 | | |
| 98 | Pharmaceutical News | journal | 0.127 Q3 | 11 | 0 | 138 | 0 | 32 | 120 | 0.33 | 0.00 | 0.00 | |
| 97 | BMC Clinical Pharmacology | journal | 0.897 Q2 | 43 | 6 | 16 | 212 | 33 | 16 | 1.33 | 35.33 | 39.29 | |
| 96 | Autonomic and Autacoid Pharmacology | journal | 0.318 Q3 | 24 | 14 | 69 | 443 | 49 | 68 | 0.71 | 31.64 | 29.55 | |
| 95 | Mathematical Medicine and Biology | journal | 0.473 Q2 | 49 | 17 | 50 | 468 | 50 | 49 | 0.94 | 27.53 | 13.95 | |
| 94 | Hospital Pharmacist | journal | 13 | 102 | 259 | 759 | 51 | 201 | 0.25 | 7.44 | 53.76 | | |
| 93 | Toxicology Mechanisms and Methods | journal | 0.205 Q4 | 55 | 50 | 79 | 1748 | 51 | 77 | 0.62 | 34.96 | 36.11 | |
| 92 | Toxin Reviews | journal | 0.267 Q3 | 54 | 23 | 78 | 1684 | 55 | 69 | 0.59 | 73.22 | 20.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data